These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34120319)

  • 1. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.
    Kaur G; Agarwal R; Sharma RK
    Food Environ Virol; 2021 Dec; 13(4):433-446. PubMed ID: 34120319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Bacteriophage Resistance in Phage Therapy.
    Laanto E
    Methods Mol Biol; 2024; 2738():401-410. PubMed ID: 37966611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
    Mikonranta L; Buckling A; Jalasvuori M; Raymond B
    Biol Lett; 2019 Mar; 15(3):20180895. PubMed ID: 30836884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?
    Singh K; Biswas A; Chakrabarti AK; Dutta S
    Curr Pharm Biotechnol; 2023; 24(10):1277-1290. PubMed ID: 36503459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
    Aranaga C; Pantoja LD; Martínez EA; Falco A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria.
    North OI; Brown ED
    Ann N Y Acad Sci; 2021 Jul; 1496(1):23-34. PubMed ID: 33175408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance.
    Oromí-Bosch A; Antani JD; Turner PE
    Annu Rev Virol; 2023 Sep; 10(1):503-524. PubMed ID: 37268007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage-layer interferometry: a companion diagnostic for phage therapy and a bacterial testing platform.
    Needham P; Page RC; Yehl K
    Sci Rep; 2024 Mar; 14(1):6026. PubMed ID: 38472239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens.
    Farooq T; Hussain MD; Shakeel MT; Tariqjaveed M; Aslam MN; Naqvi SAH; Amjad R; Tang Y; She X; He Z
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
    Fujiki J; Nakamura K; Nakamura T; Iwano H
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Phage-bacteria interplay: Future therapeutic approaches against antibiotic resistant bacteria.
    Silva-Valenzuela CA; Molina-Quiroz RC; Sillankorva S
    Front Cell Infect Microbiol; 2022; 12():1124187. PubMed ID: 36644772
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.
    Oechslin F
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the animal host in the management of bacteriophage resistance during phage therapy.
    Gaborieau B; Debarbieux L
    Curr Opin Virol; 2023 Feb; 58():101290. PubMed ID: 36512896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.